301177
Revisit Geographic Clustering of Diabetic Lower-extremity Amputation in Texas-Mexican Border Counties and Non-Border Counties
Method: A cross-sectional study design based on 2010 data was applied. The data include Texas inpatient data for identifying LEA patients, Texas BRFSS file and Area Resource File for estimating the number of diabetes patients, and the County Health Rankings and Roadmaps providing county’s health conditions. The unit of analysis is the county. The dependent variable is LEA rate, measured by the number of LEA patients divided by the estimated number of diabetes patients in the county. The key independent variables are dummy variables representing counties’ health rankings. A multivariable regression model was used for the analyses.
Results: 19 of 32 border counties were ranked as the poorest health conditions among all Texas counties. Counties ranked as the poorest health conditions have 18% higher LEA rate than counties ranked as the best health conditions (p<0.001).
Conclusion: Disparity in LEA is related to where patients resided. The approach of public health on improving health conditions of communities would provide the opportunities to reduce disparity in LEA due to geographical difference.
Learning Areas:
Chronic disease management and preventionImplementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Public health administration or related administration
Public health or related public policy
Public health or related research
Learning Objectives:
Explain why geographic clustering of diabetic lower-extremity amputation occurs in the Texas-Mexican border counties.
Evaluate the association between counties’ health conditions and diabetic lower-extremity amputation rate.
Keyword(s): Diabetes, Health Disparities/Inequities
Qualified on the content I am responsible for because: I have condcuted health services research in health outcomes and disparity and published the findings in the top-tier journals, such as Medical Care and American Journal of Managed Care. I am also the co-investigator for Medicaid 1115 waiver that focuses on improving quality of care through telehealth for Medicaid patients with chronic clinical conditions, such as diabetes and heart failure.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.